Haematology B
Corrected Count Increment (CCI) for Platelet Transfusion
Assesses response to platelet transfusion. CCI <5,000–7,500 at 1 hour OR <4,500 at 18–24 hours indicates platelet refractoriness.
References
- Hod E, Schwartz J. Platelet transfusion refractoriness. Br J Haematol. 2008;142(3):348-360.
- BCSH Guidelines for the use of platelet transfusions. Br J Haematol. 2003;122(1):10-23.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- ABC Score for Massive Transfusion · Transfusion Medicine
- Maximum Allowable Blood Loss · Transfusion Medicine
- Blood Volume Calculation (Nadler Formula) · Transfusion Medicine
- Sickle Cell Exchange Transfusion Volume · Transfusion Medicine
- Cryoprecipitate Dose Calculator for Fibrinogen Replacement · Transfusion Medicine
- Fresh Frozen Plasma (FFP) Dose Calculator · Transfusion Medicine
Drugs
- Prednisolone (Oral — General Medicine) · Oral Corticosteroid
- Becaplermin (Recombinant PDGF — Chronic Wounds) · Recombinant Human Platelet-Derived Growth Factor (rhPDGF-BB)
- Anagrelide · Platelet Reducing Agent (Specialist Drug)
- Desmopressin (Surgical — Haemostasis/Platelet Dysfunction) · Vasopressin Analogue V2 (Antidiuretic/Haemostatic)
Pathways
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Anaemia Investigation · BSH / NICE
- Splenomegaly Workup · BSH; BMJ Best Practice
- Deep Vein Thrombosis Diagnosis and Treatment · NICE CG144 / NICE NG158
- Sickle Cell Crisis · BSH 2021 / BCSH
- Neutropenic Sepsis · NICE CG151 2012 / ESMO
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.